Selank in Hangard — Anxiolytic Peptide Research Guide
Selank peptide guide for Hangard. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
For anyone in Hangard looking to source Selank, the first thing to know is that this compound moves through online research channels. This matters because Selank quality differs enormously across the market — from analytically confirmed high-purity product to mislabeled or underdosed compounds — and the vendor controls every quality variable. The core quality markers for Selank are HPLC purity ≥98%, molecular identity verified through mass spectrometry, and a bacterial endotoxin panel — all documented in a batch-matched Certificate of Analysis. The sections below cover what Hangard researchers need to know about sourcing, verifying, and handling Selank for legitimate research applications.
Understanding Selank — Biology & Evidence
Selank belongs to a class of neuropeptides with documented activity in central nervous system models. Semax (ACTH4-7 Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone fragments, and has been shown in animal and some human research to increase brain-derived neurotrophic factor (BDNF) expression — a key signal for neuroplasticity, neuronal survival, and synaptic strengthening. Selank, a synthetic analogue of the endogenous peptide tuftsin, has been shown to modulate GABAergic transmission and influence enkephalinase activity, producing anxiolytic and nootropic effects in rodent models. For researchers in Hangard studying cognitive biology and neuropeptide pharmacology, these compounds represent a productive area where mechanistic specificity is well-characterized.
How to Source Selank — Vendor Guide
Before looking at individual vendors, build a clear picture of what a proper COA looks like — so you can recognise whether a vendor meets it. The HPLC analytical chromatogram is the most important document in the COA: it should show a dominant main peak representing Selank, with negligible secondary peaks representing impurities — purity should be 98% or higher. For Hangard researchers evaluating vendors with limited track records: a small initial order to verify quality before committing to research quantities is the accepted approach among experienced researchers. For Hangard researchers making a first Selank purchase: work through this evaluation framework first, order conservatively at first, and confirm the COA batch number matches your received product before use.
Order Selank — ships to Hangard
COA-verified · International tracking · Research grade
Research compound status for Selank means safety data comes from animal studies, in-vitro work, and limited human observations — rather than the comprehensive clinical trial data that characterises approved medications. Temperature excursions — even short periods above −20°C — can compromise product integrity without visible changes; always verify cold chain was maintained during shipping. Bacterial endotoxin contamination is the greatest safety hazard associated with research-grade peptides — verify endotoxin testing is included in the batch-specific COA before any injectable research application. PubMed represent the most comprehensive research databases for Selank research; prioritise peer-reviewed studies with characterised source material over case reports or anecdotal evidence.
Frequently Asked Questions
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
